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Loss of MeCP2 in adult 5-HT
neurons induces 5-HT1A
autoreceptors, with opposite sexdependent anxiety and depression
phenotypes
Tristan J. Philippe1,2, Faranak Vahid-Ansari1,2, Zoe R. Donaldson3, Brice Le François1,
Amin Zahrai1, Valérie Turcotte-Cardin1,2, Mireille Daigle1, Jonathan James6, René Hen4,5,
Zul Merali6 & Paul R. Albert 1,2
The 5-HT1A autoreceptor mediates feedback inhibition of serotonin (5-HT) neurons, and is implicated
in major depression. The human 5-HT1A gene (HTR1A) rs6295 risk allele prevents Deaf1 binding to
HTR1A, resulting in increased 5-HT1A autoreceptor transcription. Since chronic stress alters HTR1A
methylation and expression, we addressed whether recruitment of methyl-binding protein MeCP2 may
alter Deaf1 regulation at the HTR1A locus. We show that MeCP2 enhances Deaf1 binding to its HTR1A
site and co-immunoprecipitates with Deaf1 in cells and brain tissue. Chromatin immunoprecipitation
assays showed Deaf1-dependent recruitment of MeCP2 to the mouse HTR1A promoter, and MeCP2
modulated human and mouse HTR1A gene transcription in a Deaf1-dependent fashion, enhancing
Deaf1-induced repression at the Deaf1 site. To address the role of MeCP2 in HTR1A regulation in
vivo, mice with conditional knockout of MeCP2 in adult 5-HT neurons (MeCP2 cKO) were generated.
These mice exhibited increased 5-HT1A autoreceptor levels and function, consistent with MeCP2
enhancement of Deaf1 repression in 5-HT neurons. Interestingly, female MeCP2-cKO mice displayed
reduced anxiety, while males showed increased anxiety and reduced depression-like behaviors. These
data uncover a novel role for MeCP2 in 5-HT neurons to repress HTR1A expression and drive adult
anxiety- and depression-like behaviors in a sex-specific manner.
Methyl binding proteins, such as MeCP2, are highly expressed in the brain1 and recognize epigenetic DNA methylation marks to repress gene transcription2. However, MeCP2 can also enhance transcription, in part through
interaction with other transcription factors3. MeCP2 mutations have been associated with Rett syndrome4, while
MeCP2 gene duplication associates with autism and an increased prevalence of anxiety, depression, and compulsions in patients5. Patients with Rett syndrome have reduced levels of monoamine metabolites6, similar to MeCP2
knockout mice that also display increased anxiety7. These results suggest that MeCP2 also plays a role in mood
disorders.
Depression is a complex mental health disorder that affects 16–20% of the population8,9. Depressed patients
and suicide attempters were shown to have reduced serotonergic activity10–12, are more susceptible to tryptophan depletion13,14, and have lower 5-HT metabolites in their cerebrospinal fluid15,16. The 5-HT1A autoreceptor
of the raphe nuclei inhibits pre-synaptic neuronal firing and reduces 5-HT release to negatively regulate 5-HT
1

Ottawa Hospital Research Institute (Neuroscience), University of Ottawa Brain and Mind Research Institute, Ottawa,
ON, Canada. 2Department of Cellular and Molecular Medicine, University of Ottawa Brain and Mind Research
Institute, Ottawa, ON, Canada. 3Department of Molecular, Cellular, and Developmental Biology and Department of
Psychology & Neuroscience, University of Colorado Boulder, Boulder, CO, USA. 4New York State Psychiatric Institute,
Columbia University Medical Center and Research Foundation for Mental Hygiene, New York, NY, USA. 5Department
of Psychiatry, Columbia University, New York, NY, USA. 6The Royal’s Institute of Mental Health, affiliated with the
University of Ottawa, Ottawa, ON, Canada. Tristan J. Philippe and Faranak Vahid-Ansari contributed equally to this
work. Correspondence and requests for materials should be addressed to P.R.A. (email: palbert@uottawa.ca)
SCIeNTIFIC Reports | (2018) 8:5788 | DOI:10.1038/s41598-018-24167-8

1

www.nature.com/scientificreports/
neurotransmission in the brain17. Elevated 5-HT1A autoreceptor levels have been associated with major depression and suicide, as observed in human post-mortem studies18,19 and PET imaging studies20,21. Conversely,
decreases in post-synaptic 5-HT1A heteroreceptors in prefrontal cortical areas have been associated with anxiety and depression22–25. Conditional 5-HT1A knockout and 5-HT1A transgenic mouse models have demonstrated that changes in the level of 5-HT1A receptors pre- and post-synaptically and during development can lead
to anxious, depressed, or anti-depressed phenotypes26,27. However, the transcriptional mechanisms regulating
brain-region specific 5-HT1A receptor levels in vivo are only beginning to be clarified28,29.
In humans, altered regulation of the 5-HT1A gene (HTR1A) in depression was first suggested when we identified the association of the C/G(-1019) rs6295 HTR1A polymorphism, located in the 5-HT1A promoter region30.
The association of the G(-1019) allele with depression has been replicated31,32, and it is also associated with other
disorders including anxiety, suicide, and substance abuse33–35. The rs6295 polymorphism is located within an
imperfect 26-bp palindrome, which is recognized and bound by Deaf1 at the C-allele, but not the G-allele30,36.
Impaired recruitment of Deaf1 to the HTR1A gene in 5-HT neurons is expected to increase 5-HT1A autoreceptor levels30, consistent with studies showing that the G-allele is associated with increased 5-HT1A autoreceptor binding in the raphe of depressed patients21,37. In Deaf1 knockout mice, loss of Deaf1 led to a functional
increase in 5-HT1A autoreceptors and an anxiety phenotype in males and females28,38. Conversely, the loss of
Deaf1 also led to a decrease in cortical 5-HT1A receptors, by preventing Deaf1 enhancer function that is seen
in non-serotonergic neuronal cells36. These data suggest that Deaf1 bidirectionally regulates the HTR1A gene in
different brain regions but is unable to do so at the G(-1019) variant.
In addition to genotype risk, evidence indicates that the 5-HT1A-G/G genotype is more strongly associated with psychopathology in individuals subject to environmental stressors34,39–41. While the mechanisms of
this gene-environment interaction remain elusive, early life or adult stress has been associated with changes in
site-specific DNA methylation that alter transcription factor binding, resulting in persistent changes in gene
expression42–46. The Deaf1 site in the human 5-HT1A gene contains two potential CpG DNA methylation sites,
one of which is more frequently methylated in schizophrenia and is associated with negative symptoms47. The
effect of DNA methylation on Deaf1 binding to this site is not known but would be predicted to reduce on Deaf1
binding48. Thus, we studied the potential role of MeCP2 in regulating HTR1A gene expression, its interaction
with Deaf1, and the functional effects of conditionally knocking out MeCP2 in 5-HT-producing neurons on
5-HT1A autoreceptor expression. Our findings indicate that while Deaf1 and MeCP2 interact to regulate 5-HT1A
receptor gene expression in 5-HT neurons, MeCP2 also has sex-dependent actions that impact behavior.

Results

Deaf1-MeCP2 interaction enhances recruitment to the HTR1A promoter. Because methylation of
the Deaf1 site of the 5-HT1A gene is associated with negative symptoms of schizophrenia, we addressed whether
its methylation affects Deaf1 and/or MeCP2 recruitment, since MeCP2 binds to methylated DNA. The 26-bp
human 5-HT1A Deaf1 element was inserted into a yeast one-hybrid vector and β-galactosidase activity was
measured as a read-out for recruitment of Deaf1 or MeCP2 (Fig. 1A). Since yeast lack endogenous DNA methylase, the DNA methylase transferase MSssI was transduced for comparison of methylated and non-methylated
states. Transduction of Deaf1 increased β-galactosidase activity at the C-allele, independent of DNA methylation,
an effect that was enhanced in the presence of MeCP2 (Fig. 1A, left). When expressed alone, MeCP2 was not
recruited to the Deaf1 site unless it was methylated and showed significantly more interaction at the C-allele,
which contains two CpG sites compared to one site in the G-allele (Fig. 1A, right). This result suggests that
MeCP2 can enhance Deaf1 recruitment to its site independent of DNA methylation, but in the absence of Deaf1,
MeCP2 is recruited to the Deaf1 site only upon its methylation.
To determine whether MeCP2 and Deaf1 proteins interact, pull-down assays were done in human
5-HT1A-expressing SKN-SH neuroblastoma cells co-transfected with Flag-MeCP2 and His-Deaf1 (Fig. 1B). Pull
down of His-tagged Deaf1 co-precipitated Flag-MeCP2, with weak background signal in the absence of His-Deaf1
(Fig. 1B, left). Conversely, pull down of Flag-tagged MeCP2 resulted in His-Deaf1 precipitation (Fig. 1B, right). To
confirm the Deaf1-MeCP2 interaction, IgG, Deaf1, or MeCP2 antibodies were used to immunoprecipitate endogenous proteins from extracts of SKN-SH cells, hippocampal tissue or MEFs from Deaf1 knockout or wild-type
mice. MeCP2 was detected in anti-MeCP2 precipitates in all samples, and was enriched when pulling down for
Deaf1 in SKN-SH, Deaf1 +/+ MEF and WT hippocampal extracts, but not in Deaf1 −/− MEFs and Deaf1 KO
hippocampal tissue (Supplementary Fig. S1). It was not possible to detect Deaf1 due to cross-reactivity with IgG
heavy chain, and the lack of a suitable alternate Deaf1 antibody. Taken together, these results indicate that MeCP2
and Deaf1 proteins interact.
To examine whether Deaf1 affects MeCP2 binding to the HTR1A promoter in vivo, we performed chromatin
immunoprecipitation (ChIP) assays in the Deaf1 +/+ and −/− MEF cell lines followed by PCR for the two Deaf1
sites of the mouse HTR1A promoter38 (Fig. 1C). Immunoprecipitation of Deaf1 and MeCP2 significantly enriched
the HTR1A promoter region in the Deaf1 +/+ MEFs (t(2) = 6.32, p = 0.0071 and t(2) = 6.132, p = 0.0133; post
hoc: p = 0.022; p = 0.007, respectively), but not the Deaf1 −/− MEFs (Fig. 1C; post hoc: p = 0.787; p = 0.568,
respectively). Immunoprecipitation of Histone H1, a ubiquitous component of chromatin, was used as a positive
control and significantly enriched the site in Deaf1 +/+ and −/− MEFs (Fig. 1C; t(2) = 7.202, p = 0.0078; post
hoc p = 0.0212 and p = 0.0074, respectively). The GAPDH gene, a negative control, was only enriched when pulling down with histone H1 (data not shown). To substantiate this result, similar experiments were performed in
5-HT1A-enriched brain regions including raphe, hippocampal, and prefrontal cortex (PFC) tissues from Deaf1
WT and KO mice (Supplementary Fig. S2). Pull down for Deaf1 and MeCP2 significantly enriched the site only
in the Deaf1 WT mice. Overall, these data indicate that Deaf1 binds to the Deaf1 site in vivo and is required for
MeCP2 binding to this site in mice.
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Figure 1. Deaf1-MeCP2 interaction enhances their recruitment to the HTR1A promoter Deaf1 site.
(A) MeCP2 increases Deaf1 transactivation of the human HTR1A C(-1019) site independent of promoter
methylation. At left, yeast were transduced with a combination of Deaf1-GAL4AD or vector (pACT2), MSssI
or vector (pA7WA), and MeCP2 or vector (pRS423) and the β-Gal gene fused to three copies of the human
5-HT1A 26 bp Deaf1 site with the C (1019-C) in the p8op vector. The level of β-galactosidase activity is shown
as a measure of transactivation. At right, yeast were transduced with a combination of MeCP2-GAL4AD or
vector (pACT2), MSssI or vector, and either the C or G allele of the HTR1A Deaf1 element (1019-C or 1019G). Data shown as mean ± S.E., n = 3. (B) His-Deaf1 and Flag-MeCP2 co-precipitate in co-transfected human
SKN-SH neuroblastoma cells. His-Deaf1, FLAG-MeCP2 or FLAG-vector were co-transfected in HEK-293 cells
and cell extracts (Input) analyzed by pull-down (PD) followed by Western blot for Deaf1 or FLAG (MeCP2).
Left, FLAG-MeCP2 but not FLAG was enriched upon of His-Deaf1; right, His-Deaf1 was enriched upon pulldown of FLAG (red boxes). (C) Deaf1 recruits MeCP2 to the Deaf1 sites on the mouse HTR1A promoter.
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Deaf1 −/− and +/+ MEF extracts were analyzed by ChIP using pull-down with pre-immune rabbit IgG (Ig),
n = 8; Deaf1 antibody (D1), n = 8; MeCP2 antibody (Me), n = 4; or histone H1 antibody (H1), n = 4. PCRs
of precipitated DNA were run on 2% agarose gel. Above, HTR1A promoter ChIP. The mean total luminosity
within a standard band template was quantified and normalized to the appropriate pre-immune IgG and plotted
as –fold IgG ± SE, *p < 0.05. Below: Representative PCR result showing the 200-bp and 100-bp bands of the
molecular size ladder (MW), input (in) and a negative (buffer) PCR control (−).

Deaf1 and MeCP2 modulate human and mouse HTR1A promoter activity. In order to address whether

the Deaf1-MeCP2 interaction has functional consequences, we examined their impact on the regulation of human and
mouse HTR1A transcriptional activity in HEK-293, Deaf1−/− MEFs, and raphe RN46A cell lines using luciferase
reporter assays (Fig. 2). Rat raphe RN46A cells model Deaf1 repression of 5-HT1A autoreceptor transcription in 5-HT
neurons30,36, the HEK-293 cells are a human non-neuronal cell type that lacks 5-HT1A receptors36,49 and the mouse
Deaf1−/− fibroblasts provide a Deaf1-deficient background38.
For the human HTR1A promoter, we compared the action of Deaf1, MeCP2, or both at the 1128-C or 1128-G
luciferase expression vectors (Fig. 2 left panels, Table 1). MeCP2 significantly enhanced the activity of the 1128-C
and 1128-G constructs in Deaf1 −/− MEF and RN46A cells, but had no detectable effect in HEK293 cells. These
results suggest that MeCP2 has enhancer activity at the human HTR1A promoter that does not require Deaf1 or
an intact Deaf1 site. While Deaf1 significantly repressed 1128-C activity, this effect was lost in the 1128-G variant
consistent with the inability Deaf1 to bind to the G-allele30. Co-transfection of Deaf1 and MeCP2 significantly
repressed 1128-C in all cell types, but significantly enhanced 1128-G activity in the Deaf−/− MEF and RN46A
but not HEK-293 cells. Therefore, it appears that Deaf1 can only overcome the enhancer activity of MeCP2 in
the presence of its functional site. Furthermore, the 1128-G variant was significantly de-repressed compared to
the 1128 C in all cell types (HEK-293: t(8) = 3.423, p = 0.009; Deaf1 −/− MEF: t(8) = 4.247, p = 0.0003; RN46A:
t(8) = 10.27, p < 0.0001). These data confirm that Deaf1 cannot repress the 1128-G allelic variant.
The function of MeCP2 and Deaf1 at the mouse HTR1A promoter was assessed by comparing wild-type and
Deaf1 site mutant HTR1A promoters (Fig. 2 right panels, Table 2). Since the mouse HTR1A promoter contains
two potential Deaf1 binding sites38, we mutated site 1 (m1), which is critical for Deaf1 repression38, or both Deaf1
sites 1 and 2 (m1-m2). In HEK293 cells, Deaf1 enhanced the activity of WT and m1 but not the m1-m2 mutant,
suggesting a role for site 2 in Deaf1 enhancer activity (Table 2). In RN46A and Deaf1 −/− MEF cells, Deaf1
repressed WT activity, but not m1 and m1-m2 activity, indicating a role for HTR1A Site 1 in Deaf1 repressor
activity, as observed previously using deletion mutants38. In all cell lines, MeCP2 exhibited enhancer activity that
was blocked in the m1 or m1-m2 mutant construct, suggesting that the enhancer action of MeCP2 is dependent
on Deaf1 sites. The combination of Deaf1 and MeCP2 significantly repressed the WT promoter, suggesting a
dominant effect of Deaf1 repressor activity. Interestingly, in HEK293 cells, the enhancer effects of both MeCP2
and Deaf1 were converted to a repressor effect with the combination. These repressor effects of the MeCP2-Deaf1
combination were not seen in the m1 or m1-m2 mouse HTR1A promoter variants, consistent with the importance of site 1 in Deaf1 repressor function.

MeCP2 cKO mice have higher 5-HT1A autoreceptor levels and function.

Previously we showed
that Deaf1 -/- mice have increased 5-HT1A autoreceptors, reduced raphe 5-HT levels and are more anxious than
their wild-type littermates28,38. To address the impact of MeCP2 on 5-HT1A receptor regulation and the 5-HT system in vivo, we generated mice with a conditional knockout of MeCP2 in 5-HT neurons (MeCP2TPH2 creERT2-flx/Y),
and induced this knockout in adulthood to avoid developmental complications. Immunofluorescence co-labeling
of the 5-HT1A receptors and TPH2 (5-HT neuron marker) in the raphe of MeCP2TPH2 creERT2-MeCP2/Y (WT) and
MeCP2TPH2 creERT2-flx/Y (KO) male mice revealed an almost 2-fold increase in 5-HT1A-labelled cells, with >90% of
these TPH/5-HT1A co-labeled (Fig. 3A). A small proportion of 5-HT1A-stained cells were TPH-negative, which
may reflect GABAergic interneurons, known to express 5-HT1A receptors (white arrow). In order to quantify
the level of functional 5-HT1A binding sites, brain sections were analyzed by autoradiography analysis using
125
I-MPPI, a selective 5-HT1A antagonist (Fig. 3B). In the dorsal raphe there was a significant two-fold increase
in 5-HT1A binding levels, and a similar two-fold trend in the median raphe in the knockout brains. By contrast,
the hippocampus, in which the MeCP2 gene was not targeted, showed no change in the level of 5-HT1A receptor binding. These data indicate that the loss of MeCP2 induces an increase in 5-HT1A autoreceptors, but no
change in post-synaptic 5-HT1A receptors. DPAT-induced hypothermia was assessed, since in mice it provides a
read-out of the functional activity of 5-HT1A autoreceptors in vivo. Acute injection of 8OH-DPAT, but not vehicle (saline), caused a significant reduction in temperature in both control (WT) and knockout (flx/Y) male mice,
but the drop in temperature was greater in the knockout compared to controls at all times measured (Fig. 3C;
F(11,36) = 21.234, p < 0.0001). Taken together, these results indicate that loss of MeCP2 in 5-HT neurons leads
to increased 5-HT1A autoreceptor levels and function, consistent with a role for MeCP2 to promote repression of
the HTR1A gene in serotonergic neurons in vivo.

Altered anxiety and depression-like behavior in MeCP2 cKO mice. We have recently shown that
specific de-repression of 5-HT1A autoreceptors upon knockout of the HTR1A repressor Freud-1/CC2D1A leads
to anxiety- and depression-like behaviors29. We therefore tested these behaviors in the MeCP2 cKO mice according to the timeline shown (Fig. 4). Because the behavioral effects of MeCP2 mutations are often sex-dependent50,
we also examined male and female mice separately. In the EPM test, female MeCP2 cKO mice showed increased
time in the open arms, indicating reduced anxiety (Fig. 4A). Oppositely, in the NSF test, males showed increased
latency to feed with the majority not approaching the food within 600 s, indicating strongly increased anxiety
in this test that was great enough to result in a significant genotype-dependent increase in MeCP2 cKO mice
SCIeNTIFIC Reports | (2018) 8:5788 | DOI:10.1038/s41598-018-24167-8
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Figure 2. Activity of Deaf1 and MeCP2 at human or mouse HTR1A promoter Deaf1 site mutants. Cell lines
were co-transfected with Deaf1 and/or MeCP2 constructs or appropriate empty vector controls, β-Galactosidase
(β-Gal) plasmid, and either (at left) the human 1128 C or 1128 G HTR1A promoters (hHTR1A-C or -G,
respectively) or (at right) mouse HTR1A promoter constructs wild-type (WT) or mutants of Deaf1 site 1 (m1)
or both Deaf1 sites 1 and 2 (m1-m2). Luciferase values were normalized to β-Gal, then normalized to the empty
pGL3B vector and expressed as –fold pGL3B luciferase activity. β-Gal activities were not significantly different
between samples for co-transfection of pGL3B with MeCP2 and/or Deaf1 or empty vector (data not shown).
Results from HEK-293 (n = 12), Deaf1−/− MEF (n = 9), and RN46A cells (n = 9) are plotted as Mean ± SE.
*Deaf1, MeCP2, or both vs. vector; #vector HTR1A-G vs. C or mutant vs. WT; $Deaf1 or MeCP2 alone vs.
Deaf1-MeCP2. *,#,$p < 0.05; **,##,$$p < 0.01, ***,###,$$$p < 0.001; ****,####,$$$$p < 0.0001 (see Supplementary
Tables 1, 2 for statistics).

(Fig. 4B). No differences between genotypes or sexes were seen in the OF anxiety test (Fig. 4C), nor in the BBK
test, a control for locomotion activity (data not shown). These data suggest an opposite effect of the loss of MeCP2
in 5-HT neurons on anxiety in males and females. In the FST and the TS, the MeCP2 cKO mice showed reduced
immobility times, driven mainly by the male mice (Fig. 4D,E). This suggests that loss of MeCP2 in 5-HT neurons
results in reduced depression-like behaviors, especially in males. Thus in males, deletion of MeCP2 in 5-HT
neurons leads to increased 5-HT1A autoreceptor levels that is associated with increased anxiety and reduced
depressed-like behaviors, while in females an anti-anxiety phenotype is seen in the EPM.
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+1.5#

RN46A

+1.4

−1.6

−1.7

+2.1

1

+1.3

Table 1. Summary of the effects of Deaf1 and MeCP2 on activity of the human HTR1A promoter. Shown is
the -fold effect of Deaf1 (D), MeCP2 (M) or both (MD) on 1128-C and 1128-G HTR1A promoter activity in
luciferase reporter assays, normalized to the expression vector with empty Deaf1 and MeCP2 vector controls
(1x). Significant (p < 0.05) increases (+) and decreases (−) are in bold. #p < 0.10.
WT
HEK 293

m1

m1&m2

M

D

MD

M

D

MD

M

D

MD

+2.3

+3.4

−1.5

1

+3.5

1

+1.2

1

+1.2

MEF Deaf1−/−

+1.7

−1.8

−2.4

1

1

1

1

1

1

RN46A

+2.0

−2.8

−3.5

+1.1

1

1

1

1

1

Table 2. Summary of the effects of Deaf1 and MeCP2 on activity of the mouse HTR1A promoter Shown is the
-fold effect of Deaf1 (D), MeCP2 (M) or both (MD) on wild-type (WT) and mutants at site 1 (m1) and sites 1
and 2 (m1&m2) mouse HTR1A promoter activity in luciferase reporter assays, normalized to the expression
vector with empty Deaf1 and MeCP2 vector controls (1x). Significant (p < 0.05) increases (+) and decreases (−)
are in bold.

Discussion

Deaf1-dependent recruitment of MeCP2 to the HTR1A promoter.

Because both Deaf1 and DNA
methylation have been implicated in HTR1A regulation, we examined their role in MeCP2 activity at the HTR1A
promoter. Deaf1 binds the HTR1A promoter in an allele-specific manner, with the non-binding G(-1019) allele
associated with major depression, anxiety and resistance to antidepressant and atypical antipsychotic treatment31–33,51. DNA methylation of the Deaf1 site is associated with negative symptoms of schizophrenia and correlates with antipsychotic resistance47. Using yeast one-hybrid and ChIP assays, we show that MeCP2 is recruited
to this site indirectly via binding to Deaf1 and directly via CpG methylation of the site. We show that Deaf1
and MeCP2 co-precipitate, indicating that this recruitment likely involves Deaf1-MeCP2 protein interactions,
although we cannot rule out involvement of other cofactors (e.g., co-repressor complexes52–55). Although mainly
expressed in forebrain, MeCP2 was recruited to the Deaf1 sites of the mouse HTR1A promoter in the prefrontal
cortex, hippocampus, and raphe-midbrain, implicating it in regulation of both pre- and post-synaptic 5-HT1A
receptor expression. Interestingly, under basal (non-stressed) conditions, recruitment of MeCP2 to the HTR1A
was entirely Deaf1-dependent and was absent in the Deaf1−/− mice. Thus, Deaf1 is required for recruitment of
MeCP2 to regulate basal mouse HTR1A promoter activity in cells and in vivo.

Deaf1 and MeCP2 coordinately regulate HTR1A expression. Transcriptional reporter assays in three
cell models revealed a novel interaction between Deaf1 and MeCP2 activities on mouse and human HTR1A promoters. Mutation of the Deaf1 site led to a de-repression of HTR1A activity, preventing Deaf1, Hes1/5 or other
repressor functions. Transfection of Deaf1 repressed HTR1A promoters, which was dependent on the C(-1019)
human allele or Site 1 in the mouse HTR1A. In HEK-293 cells, Deaf1 displayed enhancer activity at the mouse
HTR1A Site 2, identifying a new role for this site in Deaf1 action. Deaf1 has previously been shown to have
repressor or enhancer activity depending on cell type and promoter, however the mechanisms determining Deaf1
activity remain unclear. In contrast to Deaf1, MeCP2 increased transcription of the mouse HTR1A in all cell
lines, which required Deaf1 Site 1. However, at the human HTR1A promoter this effect was independent of Deaf1
(in Deaf1−/− MEFs) and the Deaf1 site (in the G(-1019) allele), suggesting that other MeCP2 mechanisms are
involved. Importantly, co-transfection of MeCP2 and Deaf1 converted MeCP2 or Deaf1 enhancer effects into a
strong repressor effect in all cell lines and this effect was dependent on the Deaf1 site in human and mouse (Site
1). This indicates that recruitment of MeCP2 by Deaf1 strengthens Deaf1-MeCP2 repression and prevents their
enhancer functions, providing a novel mechanism for MeCP2 mediated repression via Deaf1.
Role of MeCP2 in HTR1A expression in vivo.

To address the function of MeCP2 in HTR1A regulation
in vivo we generated MeCP2 cKO mice with targeted MeCP2 deletion in adult 5-HT neurons. We demonstrate
that loss of MeCP2 increases 5-HT1A autoreceptor levels and function, consistent with a repressor function for
MeCP2 in 5-HT neurons. Similarly, knockout of Deaf1 or conditional knockout of HTR1A repressor Freud-1/
Cc2d1A in adult 5-HT neurons results in increased 5-HT1A autoreceptor levels and function in 5-HT neurons,
while reducing raphe 5-HT levels28,29,38. In contrast, a recent study of MeCP2 -/y male mice did not observe
changes in brainstem 5-HT1A receptor RNA, but may have missed changes in 5-HT neurons, which constitute a fraction of cells in brainstem56. In humans with Rett syndrome, inactivating mutations of MeCP2 result
in an age-progressive reduction in CSF 5-HIAA, also seen in mice with lifelong knockout of MeCP2 in 5-HT
neurons7. However, in the MeCP2-cKO mice there was no change in 5-HT or 5-HIAA in the raphe, hippocampus or prefrontal cortex (Fig. S3), suggesting a developmental effect of MeCP2 is required for this phenotype.
SCIeNTIFIC Reports | (2018) 8:5788 | DOI:10.1038/s41598-018-24167-8
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Figure 3. Increased 5-HT1A autoreceptor levels and function in MeCP2 cKO mice. Male TPH2creERT2MeCP2flx/Y conditional knockout (KO) and control littermates (WT) mice were treated with tamoxifen at 8
weeks of age and perfused three weeks later. (A) Dorsal raphe slices were stained with TPH (sheep anti-TPH,
1:100) and 5-HT1A receptors (rabbit anti-5-HT1A, 1:50). Representative sections are shown at left; arrows
show a small group of 5-HT1A + /TPH-negative cells; scale bar indicates 50 μm. Right, total 5-HT1A- and
TPH-positive cells were counted in dorsal raphe sections and quantified (n = 3 animals) as mean ± SEM (for
5-HT1A: WT, 206 ± 6.5 vs. KO, 369 ± 43.8, t test, t = 3.691732 df = 4, *p = 0.0210; for TPH, WT, 281.7 ± 35.8
vs cko, 268.7 ± 58.4, t test, t = 0.1898 df = 4, p = 0.8587). (B) 5-HT1A receptor autoradiography. 125I-MPPI
autoradiography was performed using raphe (containing dorsal (DR) and median (MR)) and hippocampal
(Hippo) slices (representative sections shown at left). At right, signal/region template was quantified as
mean ± SEM (n = 3) (for DR: WT, 1.35 ± 0.10 vs cko, 2.62 ± 0.28, t test, t = 4.244 df = 4, *p = 0.0132; for MR:
WT, 0.768 ± 0.145 vs cko, 1.56 ± 0.273, t test, t = 2.563 df = 4, p = 0.0625; for hippocampus, WT, 3.81 ± 0.386
vs cko, 3.50 ± 0.195, t test, t = 0.7246 df = 4, p = 0.5088). (C) DPAT-induced hypothermia. Mice were injected
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with 0.9% saline (vehicle) or 0.5 mg/kg 8-OH-DPAT at 0 min (temperature change = 0) and rectal temperatures
measured at 10-min intervals thereafter, averaged and subtracted from mean pre-injection temperature, over
a 60-min time period (n = 5 WT; n = 3 Flx/Y KO). Data are shown as mean ± SE; **p < 0.01; ***p < 0.001 by
two-way ANOVA with Bonferonni post-test, comparing DPAT-treated Flx/Y to WT.
Thus, knockout of these key HTR1A repressors each increased 5-HT1A autoreceptor expression and function.
Although MeCP2 negatively regulates 5-HT1A autoreceptor expression in mice, it remains unknown whether
5-HT1A receptor dys-regulation also occurs in humans with Rett syndrome.

Loss of MeCP2 in adult 5-HT neurons sex-dependently alters behavior. Behaviorally, MeCP2
cKO mice had a striking sex-dependent anxiety phenotype, which mirrors that in global MeCP2 knockout
mice. Female MeCP2 cKO mice showed reduced anxiety in the EPM test, while male MeCP2 cKO mice showed
increased anxiety in the NSF test. Similarly, female MeCP2+/− mice show reduced anxiety-like behavior in
EPM and light-dark (LD) box tests57, suggesting an anxiogenic role for MeCP2 in 5-HT neurons in female mice.
Oppositely, male MeCP2 −/y mice showed increased anxiety in the EPM, OF and LD tests58. The sex-dependent
anxiety phenotype in our MeCP2 cKO mice matches that in global MeCP2 knockout mice, suggesting that loss of
MeCP2 in 5-HT neurons may drive the anxiety phenotype in MeCP2 gene deletion models.
The reduced anxiety in females differs from the anxiety phenotype seen upon loss of HTR1A repressors
Freud-1 and Deaf1. Loss of Freud-1 in adult 5-HT neurons increased anxiety- and depression-like behaviors in
both sexes29. The increase in anxiety-like behavior in male MeCP2 cKO mice is similar to what is seen in Freud-1
cKO mice and implicates 5-HT1A autoreceptor up-regulation, which may partly account for anxiety in human
male MeCP2 mutation carriers. In contrast, global Deaf1 −/− mice showed increased anxiety-like behavior that
was sex- and test-dependent28. Deaf1 −/− females showed increased anxiety in the EPM and OF, but reduced
anxiety in the light-dark test, while males showed increased anxiety in the light-dark test. In MeCP2 cKO mice,
females showed reduced anxiety in the EPM, suggesting that MeCP2 has a Deaf1- and HTR1A-independent effect
on female anxiety.
Our results suggest reduced depression-like behavior in males lacking MeCP2 in 5-HT neurons. Unlike other
MeCP2 deletion mouse models59,60, we found no evidence for motor impairment in distance travelled in the BBK,
OF or EPM tests, suggesting that the 5-HT system does not contribute to this phenotype. Due to the locomotor
impairment, the FST is not feasible in MeCP2 -/y mice61, hence depression-like behavior has not been evaluated.
Interestingly, patients with MeCP2 duplication display both anxiety and depression5. Conditional knockout of
Freud-1 in mice lacking 5-HT1A autoreceptors elicited a similar anti-depressed phenotype as in MeCP2 cKO29.
Since up-regulation of 5-HT1A receptors increases depression-like behavior, like Freud-1, MeCP2 may target
other genes in 5-HT neurons to alter this phenotype.
The mechanisms underlying the sex-specific behavioral effect of MeCP2 are unclear. One major role of MeCP2
in gene regulation is sex-dependent parental imprinting by silencing of the methylated paternal chromosome62,63.
In the brain, post-natal deletion of the chromatin remodeling protein ATR-X results in a loss of MeCP2-mediated
inactivation and induction of imprinted genes in females64. A similar mechanism of female-specific gene regulation in adult 5-HT neurons could mediate the reduced anxiety in female MeCP2 cKO mice, but only if imprinted
gene expression is reversible within 3 weeks of tamoxifen-induced MeCP2 knockout. Our results with HTR1A
suggest that loss of MeCP2 can alter gene expression in this time frame.

Conclusion

In summary, we have identified a novel MeCP2-Deaf1 interaction that enhances Deaf1 recruitment to the Deaf1
element of the HTR1A promoter, and switches on Deaf1-induced repressor activity. In the presence but not
absence of Deaf1, both Deaf1 and MeCP2 bind to this site in vivo. Deaf1 and MeCP2 bind to the Deaf1 site in the
mouse HTR1A promoter in vivo. Like Deaf1, knockout of MeCP2 enhanced 5-HT1A autoreceptor expression,
suggesting that both play a role in HTR1A promoter regulation and contribute to anxiety or depression phenotypes. In males, MeCP2 in 5-HT neurons may mediate protection from anxiety but predisposition to depression,
while in females, MeCP2 may drive anxiety.

Methods

Yeast one-hybrid. As described previously30, three repeats of either the C or G allele containing 26-bp Deaf1
element were fused to p8op-SN-LacZ, a β-galactosidase reporter plasmid (generously provided by Dr. Takahi Ito,
Kanazawa University, Japan); the Gal4AD pACT2 plasmid was fused to Deaf1 (Clontech), and the pRS423 plasmid was fused to MeCP2 (Clontech). The PJ69-2A yeast strain (from Dr. Ito) was used to transform combinations
of vectors including M.SssI (pLexA-MSssI), to analyse the effects of gene methylation65. β-galactosidase activity
was measured using ortho-Nitrophenyl-β-D-galactopyranoside substrate.
Cell lines. Human SKN-SH neuroblastoma, human HEK-293, and mouse Deaf1 +/+ and −/− mouse embryonic fibroblasts (MEFs) were grown in DMEM with 4.5 g/L glucose, without sodium pyruvate (Wisent) with
10% v/v heat-inactivated FBS (Wisent) at 37 °C and 5% CO2. Rat RN46A raphe cells were grown in Neurocell
(Wisent) with 10% heat-inactivated FBS (Wisent) at 33 °C and 5% CO230. To prepare MEFs, heterozygous Deaf1
females and males were bred and checked daily for plugs. Pregnant females were euthanized and MEFs isolated
as described66 from embryos genotyped for Deaf138. MEFs were immortalized using the pWP TS A58 lentiviral
vector.
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Figure 4. Sex-dependent changes in anxiety- and depression-like behavior in MeCP2 cKO mice. Mice were
treated with tamoxifen (Tam), and subjected to behavioral tests according to the timeline shown and sacrificed
one day after the last test (Sac). Male (M) and female (F) or pooled homozygous WT and MeCP2 cKO mice
were compared (N = 8, WT/F and MeCP2/F; N = 11, WT/M; N = 9, MeCP2/M). (A) EPM test. Compared to
WT, female MeCP2 mice spent more time in open arms (one-way ANOVA sex X genotype interaction, F3,
33 = 12.96, p < 0.001; post-hoc Tukey WT/F vs MeCP2/F ***p = 0.0002; MeCP2/F vs MeCP2/M p < 0.0001)
with no difference detected in closed arm time, indicative of reduced anxiety in females. (B) NSF test. Male
(one-way ANOVA sex X genotype interaction, F3, 30 = 6.702, p = 0.0014; post-hoc Tukey WT/M vs MeCP2/M
***p = 0.0032) and pooled MeCP2 cKO mice showed greater latency to approach food in the novel arena (WT,
279.4 ± 40.90 vs cko, 502.6 ± 38.44, t test, t = 3.892 df = 32, ***p = 0.0005), but no difference was seen in the
home cage indicating increased anxiety. (C) FST test. Pooled MeCP2 cKO mice showed greater immobility
time (WT, 75.15 ± 10.31 vs MeCP2 36.78 ± 3.204, t test, t = 3.615 df = 47, ***p < 0.0001, and males showed a
strong trend (one-way ANOVA sex X genotype interaction F3, 31 = 2.791, p = 0.0569; post-hoc Tukey WT/M
vs MeCP2/M, p = 0.055), indicating reduced depression-like behavior. (D) TST. Male (one-way ANOVA sex X
genotype interaction F3, 31 = 4.080, p = 0.0149, post-hoc Tukey WT/M vs MeCP2/M, *p = 0.0164) and pooled
MeCP2 cKO mice showed lower immobility time (WT, 254.0 ± 6.586 vs MeCP2, 222.4 ± 13.15, t test, t = 2.186
df = 33, *p = 0.0360), indicating reduced depression-like behavior in male MeCP2 cKO mice.

Plasmid Constructs. As described previously30, 1128 C or 1128 G include 1128 bp upstream of the human
5-HT1A translational initiation site (TIS), with either the C or G (-1019) allele; the mouse 984 construct includes
984 bp upstream of the mouse TIS38. The WT1A, m1, and m1&m2 include 1438 bp upstream of the mouse 5HT1A
TIS. In the m1 mutant 5′-CTCGTG is changed to 5′-TGCCGG and in the m1&m2 mutant 5′-GTCGAC of the
second Deaf1 site is also replaced with 5′-GCGGCA. Transcription vectors included the pcDNA3-His-human
Deaf130 (denoted as Deaf1) or empty pcDNA3 vector and pFLAG-human MeCP2 (denoted as MeCP2) or the
empty pcDNA3-FLAG (pFLAG) vector.
Transfection and Luciferase Assays.

MEFs grown to 90% confluence in a 5-cm dish (Corning) were
transfected with 1.5 μg of Deaf1, MeCP2 and/or reporter plasmids or respective controls, 0.5 μg of β-Galactosidase
and 10 μL of Fastfect (Feldan) for 5 μg total DNA. HEK-293 cells at 70% confluence in a 5 cm plate were transfected with 2.5 μg of each plasmid except for 0.5 μg of β-galactosidase using calcium-phosphate co-precipitation67.
RN46A cells grown to 60% confluence in a Primaria (Falcon) 10-cm dish were transfected with 3 μg of each vector
except for 0.5 μg of β-galactosidase using 19 μL of Lipofectamine 3000 and 5 μL of Plus reagent (ThermoFisher,
Ottawa ON) for 9.5 μg of DNA (2:1 lipid:DNA ratio).
For luciferase assay, 48 hr after transfection cells were lysed with reporter lysis buffer (Promega) and luciferase luminescence read by a GloMax-96 microplate luminometer (Promega). β-galactosidase activity was measured using a LS50 spectrophotometer (Perkin-Elmer) and used to correct luciferase activity, which was then
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normalized to the appropriate pGL3B empty vector control and data expressed as a percentage of pGL3B activity.
No significant difference in activity was found between pGL3B and empty vector controls.

Co-immunoprecipitation. Lipofectamine 2000 (ThermoFisher) was used to transfect SKN-SH cells42 with

pcDNA3-HIS-Deaf1 and pFLAG-MeCP2 or respective controls. All cells were grown to 80–90% confluence.
Brain extracts were from 10 week-old mice and were minced. Samples were lysed with FLAG buffer (with protease inhibitors) and homogenized with 25 strokes of the large and small clearance pestle in a chilled 7 mL glass
Dounce homogenizer. Lysates were centrifuged at 15000 rpm for 15 min at 4 °C and quantified. Lysates from
transfected SKN-SH (500 μg/500 μL) were rotated for 1 hr with 100 μL of cobalt beads (Thermo Fisher; binds the
HIS tag) or overnight (16 h) with 100 μL of anti-FLAG beads (Sigma) at 4 °C. Lysates of endogeneous proteins
from cells and brains (1500 μg/1 mL) were incubated at 4 °C for 16 h with pre-immune IgG (1:50 v/v), anti-Deaf1
homemade rabbit antibody (1:50 v/v), or anti-MeCP2 rabbit antibody (Millipore CAT.# 07–013; 1:100 v/v), and
incubated with 200 μL of protein A-Sepharose bead slurry (Sigma) per 1 mL of lysate for 2 h at 4 °C. Beads were
then washed at 4 °C 5 times with 500 μL of FLAG lysis buffer and protease inhibitors, then resuspended in 1x
Laemmli loading buffer (60 uL), boiled for 5 min, and centrifuged at 12000 g × 3 min to remove insoluble debris.
Entire sample supernatants were loaded on Western blot, stained with either Anti-FLAG tag rabbit antibody
(1:2000; Millipore); anti-Deaf1 rabbit polyclonal antibody against homemade recombinant full-length human
Deaf1 (1:500 v/v); anti-MeCP2 chicken antibody (Millipore CAT.# ABE171; 1:1000 v/v); or anti-β-actin mouse
antibody (Sigma), followed up by the appropriate HRP-conjugated (Sigma; 1:4000) secondary antibody, and HRP
substrate (Millipore). Finally, these were detected with the Image Quant LAS4010 (GE) or Kodak film and presented in compliance with the digital image and integrity policies.

Chromatin immunoprecipitation.

Brain extracts from 10 week-old mice were minced and cells were
grown to 80–90% confluence and processed as described previously42. However, samples were sonicated for
30 min at 4 °C using a 70 W, 40 KHz Ultra-sonic water bath (1.9 L) MH series, model 15-337-401 (ThermoFisher)
and ChIP grade glass beads (0.1 g per 1 mL of lysate; Sigma). Beads were removed and supernatants (1500 μg/
mL of ~500 bp DNA) were incubated with either pre-immune rabbit IgG (1:50), Deaf1 rabbit homemade antibody (1:50)38, MeCP2 rabbit antibody (1:100; Millipore CAT.# 07–013), or rabbit anti-Histone H1 (1:200, Abcam
CAT.# AB31972) with constant rotation at 4 °C overnight. Samples were incubated for 2 h at 4 °C with 200 μL of
Protein A-Sepharose beads (Sigma) in PBS, 250 μg/mL BSA and 100 μg/mL sonicated salmon sperm per 1 mL
of sample. Samples were then washed, de-crosslinked and the DNA isolated as previously described42. PCR was
performed using the mouse HTR1A promoter primers that encompass both Deaf1 binding sites (a 180-bp PCR
product) and the mouse GAPDH promoter primers (a 179-bp PCR product)38. The PCR was performed using
200 μM dNTP, 1 μM of each primer, 2.5 U of Taq polymerase (NEB). Cycling conditions were: 95 °C for 1 min; 40
cycles of 95 °C for 30 sec, 59 °C (for HTR1A)/56 °C (for GAPDH) for 45 sec, 72 °C for 15 sec, and final extension
at 72 °C, 5 min.

Mice housing, breeding and genotyping. The University of Ottawa Animal Care Committee approved
all animal protocols and all experiments were performed in accordance with University of Ottawa Animal Care
Committee guidelines. Animals were housed with ad libitum food and water, on a 12-hour light/dark cycle
(lights on at 6:00 AM), at 21 °C. TPH2CreERT2 (#016584) and MeCP2 (#007177) mice were obtained from Jackson
Laboratories (Bar Harbor, ME) and interbred on a C57Bl/6 background. At 3 weeks of age an ear notch was
taken for genotyping and extracted using the REDExtract-N-Amp Tissue PCR kit (Sigma). The PCR to genotype
MeCP2 was done using red dye Taq PCR master mix (BioBasic) and 4 μM of the following primers: forward
5′-GCCACATGACAAGACAAAAACA; reverse 5′-GTTACACCG CTGAAATCTCTTG. The PCR conditions
were: 94 °C for 4 min; 34 cycles of 94 °C for 30 sec, 57 °C for 30 sec, 72 °C for 30 sec; 72 °C for 10 min generating
238-bp (wild-type) or 313-bp (flx-MeCP2) products. TPH2CreERT2 PCR was performed using 1x EasyTaq buffer
(Transgen Biotech), 200 μM dNTP, 0.05 U of EasyTaq polymerase (Transgen Biotech), 2 μM of each respective primers: 11679 5′-GCTGAGAAAGAAAATTACATCG and 12523 5′-TGGCTTGCAGGTACAGGAGG;
and internal positive controls: OIMR8744 5′-CAAATGT TGCT TGTCTGGTG and OIMR8745
5′-GCTAGTCGAGTGCACAGTTT. Cycling conditions were: 94 °C for 1 min; 35 cycles of 94 °C for 15 sec, 57 °C
for 20 sec, 72 °C for 10 sec; and 72 °C for 2 min with a 300-bp TPH2CreERT2 product and 200-bp internal positive
control. Each mouse used in this study was genotyped at weaning and verified at sacrifice. For Cre activation, at 8
weeks of age mice were injected with tamoxifen (180 mg/kg/day, i.p; Sigma T56648) for four consecutive days.
Using this protocol we obtain ~90% recombination specific to 5-HT cells29. Tamoxifen (30 mg/mL; Sigma CAT #
T5648-5G) was prepared at 30 mg/ml in 1:9 ethanol:sunflower seed oil (Sigma).
5-HT1A level and function experiments.

Co-immunofluorescence for 5-HT1A receptors and TPH,
5-HT1A receptor autoradiography and DPAT-induced hypothermia were performed and quantified as described
previously28,29 using 10–11 week-old mice. For immunostaining; antibodies used included sheep anti-TPH,
(Abcam, ab1541 1:100) and rabbit anti-5-HT1A receptor raised to the second intracellular loop of the 5-HT1A
receptor (Cedarlane, Hornby, ON, Canada, 1:50)38. The secondary antibodies used were anti-sheep Cy3 (Jackson,
713-165-003, 1:200) and Alexa Fluor 488 anti-rabbit (ThermoFisher, A-21206, 1:1000). Images were acquired
using Axiovision imaging software on a Zeiss Axio Observer D1 microscope (n = 3/group). Positive-stained
cells were manually counted in every 4th section (4/region; Bregma 4.36 to 4.72 mm) within a standardized template surrounding the structure of interest, using ImageJ 1.48 v software. 5-HT1A autoradiography of frozen
25-µm sections of dorsal raphe or hippocampus was done using 125I-MPPI (Perkin Elmer, Boston, MA) as previously described28,68 (n = 3). Signals were within the linear range of the film and quantified based on standard curve using ARC146-F 14C standards (American Radiochemicals Inc, St. Louis, MO). 8OH-DPAT-induced
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hypothermia was performed from 9–11 AM as described previously, with 3 baseline temperature measurements,
administration of 8OH-DPAT (0.5 mg/kg, i.p., Sigma), followed by measurements at every 10 minutes29. The baseline values were averaged and the difference between the average baseline and recorded temperature was plotted
across time.

Behavioral studies. Behavioral tests were conducted in littermates starting 2 weeks after the last tamoxifen
injection, at 11 weeks of age (see timeline, Fig. 4). Mice were housed under normal light conditions (lit from 6:00–
18:00) and tests were performed beginning at 10:00, after at least 1 h of habituation to the testing room. Testing
was performed as described previously29 and completed within 10 days in the following order: elevated plus maze
(EPM); open field (OF); tail suspension (TS); forced swim test (FST); novelty suppressed feeding (NSF); and
beam break test (BBK). All animals were of the same age at the start of testing and all tests were done in the above
order and completed within 12 days. Each cohort included 10–32 mice/group. Throughout testing and behavioral
analyses, the experimenter was blind to the mouse genotype.
High Performance Liquid Chromatography (HPLC) Analysis. Levels of 5-HT and 5-HIAA were
quantified in extracts of dissected tissues by HPLC29. For HPLC, MeCP2 KO and matched WT littermate mice
(n = 4, 11 wks old) were sacrificed by cervical dislocation and decapitation.
Statistical analyses. Graphs were made using Microsoft Excel and present means and standard error (SE)
calculated. Statistical calculations (as specified in figure/table legends) were performed using Graphpad Prism
6.00 for Windows. For behavioral studies, no animals were excluded. For multiple comparisons, two-way ANOVA
was used, with Bonferroni or Tukey post-test. Minimum significance was set at p < 0.05.
Data availability.

The datasets generated and/or analyzed during the current study are available from the
corresponding author on reasonable request.
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